What Is Driving Global AI In Cancer Diagnostics Market Growth in 2025: The Role of Rising Cancer Cases Propel Advances Artificial Intelligence Takes Center Stage In Cancer Diagnostics

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

AI In Cancer Diagnostics Market Size Growth Forecast: What to Expect by 2025?
The valuation of the artificial intelligence within cancer diagnostics sector has experienced rapid escalation lately, projected to increase from a figure of $0.66 billion during 2024 to $0.79 billion in 2025, reflecting a consistent compound annual growth rate of 21.0%. This upward trajectory observed across the historical period stems from several key factors, namely the rising prevalence of cancer diagnoses, the massive influx of healare data, a favorable regulatory landscape, a heightened emphasis on personalized treatment approaches, and the broadening scope of AI utilization beyond just image analysis.

How Will the AI In Cancer Diagnostics Market Size Evolve and Grow by 2029?
The artificial intelligence sector within cancer diagnostics is projected to experience rapid and substantial expansion over the upcoming years, reaching a valuation of $1.65 billion by 2029, fueled by a compound annual growth rate (CAGR) of 20.0%. This augmented growth throughout the projection timeframe is primarily driven by several factors: the advent of transparent, explainable AI methodologies, a worldwide tendency towards increased expenditure in health information technology, the seamless incorporation of AI systems with electronic health records (EHR) infrastructure, the broader adoption of individualized treatment approaches, and ongoing refinements in AI computational models. Key developments shaping this period involve progress in medical imaging techniques, the merging of different technologies, stronger partnerships formed between medical institutions and technology firms, the growing prominence of digital pathology workflows, and increased automation within the field of histopathology.

View the full report here:
https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

What Drivers Are Propelling the Growth of AI In Cancer Diagnostics Market Forward?
Anticipated expansion in cancer incidence is set to fuel the advancement of artificial intelligence within the sphere of cancer diagnostics. Cancer, characterized by uncontrolled cellular multiplication that may metastasize throughout the organism, presents a significant public health challenge. The incorporation of AI technologies into oncological management endeavors to boost operational effectiveness, diagnostic precision, and tailored therapeutic strategies, thereby leading to better results for individuals afflicted with the disease. Illustratively, data from the US-based governmental organization, the National Cancer Institute, indicated in May 2024 that, for the year 2024, the US anticipates roughly two million new cancer diagnoses alongside projections of upwards of 611,000 fatalities. Looking forward to 2040, global estimates suggest that newly identified cancer cases could reach 29.9 million, accompanied by a rise in cancer-related mortalities to 15.3 million. Consequently, the escalating frequency of cancer serves as a primary catalyst for the development of artificial intelligence solutions in cancer diagnostic tools.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13567&type=smp

Which Emerging Trends Are Transforming the AI In Cancer Diagnostics Market in 2025?
Leading firms within the sphere of artificial intelligence applications for cancer diagnosis are witnessing considerable expansion, a trend fueled by progress in digital pathology systems leveraging AI for identifying malignancies. These sophisticated AI-driven digital pathology tools analyze various tissue samples using machine learning algorithms to pinpoint cancerous cells and critical diagnostic markers, thereby facilitating precise and prompt cancer identification, assisting in determining the urgency of patient cases, and ensuring consistency in diagnostic outcomes. By way of illustration, in the eleventh month of 2023, Dedalus and Ibex Medical Analytics, a European health software entity, released a comprehensive, fully integrated AI-enabled digital pathology offering tailored for cancer detection throughout the European continent, with the stated objectives of boosting diagnostic precision, equipping users with AI-based decision support mechanisms, rationalizing the documentation process, improving overall laboratory throughput, and bolstering the certainty of diagnoses.

What Are the Key Segments in the AI In Cancer Diagnostics Market?
The ai in cancer diagnosticsmarket covered in this report is segmented -

1) By Component: Software Solutions; Hardware; Services
2) By Cancer Type: Breast Cancer; Lung Cancer; Brain Tumor; Skin Cancer And Cervical Cancer; Prostate And Colorectal Cancer; Other Cancer Types
3) By Application: Screening And Diagnosis; Tumor Identification; Monitoring
4) By End User: Hospitals; Diagnostic Centers; Medical Research Institutes; Contract Research Organizations

Subsegments:
1) By Software Solutions: Machine Learning Software; Deep Learning Software; Image Analysis Software
2) By Hardware: AI-Powered Imaging Systems; Diagnostic Devices
3) By Services: AI Integration Services; Consulting And Training Services; Support And Maintenance Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13567&type=smp

Who Are the Key Players Shaping the AI In Cancer Diagnostics Market's Competitive Landscape?
Major companies operating in the AI in cancer diagnostics market report are Microsoft Corporation, IBM Corporation, Babylon Healare Services Ltd., Verily Life Sciences LLC, Tempus, Guardant Health, Lunit Inc., Paige AI Inc., Ada Health GmbH, Viz.ai Inc., erfly Network Inc., Insilico Medicine, BenevolentAI SA SA, Enlitic Inc., Ibex Medical Analytics, Kheiron Medical Technologies Limited, CureMetrix Inc., CancerIQ Inc., MultiplAI Health, Freenome Holdings Inc., SkinVision, Entopsis, Owkin, Imagen Technologies, Panakeia Technologies, EchoPixel Inc., X-Zell Inc., Cyrcadia Health, Oncora Medical, Xilis

What Geographic Markets Are Powering Growth in the AI In Cancer Diagnostics Market?
North America was the largest region in the artificial intelligence in cancer diagnostics market in 2024. The regions covered in the ai in cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13567

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.